Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$298 | -$215 | -$164 | -$108 |
| Dep. & Amort. | $3 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $69 | $41 | $28 | $17 |
| Change in WC | $12 | $8 | $19 | $1 |
| Other Non-Cash | -$11 | -$2 | $1 | -$1 |
| Operating Cash Flow | -$226 | -$166 | -$115 | -$89 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$5 | -$2 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,147 | -$533 | -$330 | -$125 |
| Inv. Sales/Matur. | $576 | $337 | $157 | $69 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$575 | -$200 | -$174 | -$56 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $970 | $369 | $117 | $250 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $40 | $20 | $5 | $3 |
| Financing Cash Flow | $1,010 | $389 | $122 | $253 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $210 | $22 | -$167 | $108 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56 | $34 | $201 | $94 |
| End Cash | $266 | $56 | $34 | $201 |
| Free Cash Flow | -$230 | -$171 | -$117 | -$89 |